Martin Münchbach

Managing Partner at Pureos Bioventures

Martin Münchbach is a venture capital investor since 1999, investing in life science companies across all stages and types. Joined Bellevue Group in 2004. Martin’s investments and board assignments include Bellevue’s most successful private biopharmaceutical investments, such as Radius Health, Molecular Partners, Optimer, Axovan and Glycart. PhD Protein Chemist & Biochemist.

Links

Previous companies

Lava Therapeutics B.V. logo
binx health logo

Org chart

Sign up to view 0 direct reports

Get started